Live Breaking News & Updates on Applied therapeutics

Stay informed with the latest breaking news from Applied therapeutics on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Applied therapeutics and stay connected to the pulse of your community

Is Myocardial Infarction Overdiagnosed?

This Viewpoint examines whether overdiagnosis rather than underdiagnosis may now be the dominant form of myocardial infarction misdiagnosis.

United-states , United-kingdom , Massachusetts , Boston , Jamesl-januzzi-jr , American-college-of-cardiology , Astrazeneca , Imbria-pharmaceuticals , Boehringer-ingelheim , Medtronic , Pfizer

Applied Therapeutics (NASDAQ:APLT) Trading Up 4.2%

Applied Therapeutics (NASDAQ:APLT) Trading Up 4.2%
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Canada , United-states , Leslied-funtleyder , Leerink-partnrs , Shoshana-shendelman , Vontobel-holding-ltd , Therapeutics-company-profile , Securities-exchange-commission , Nasdaq , Northern-trust-corp , Citigroup , Royal-bank

New Drug Fails to Improve Diabetes-Related Heart Failure

Subanalysis finds benefit for patients not on heart-beneficial antidiabetic medication

Massachusetts , United-states , James-januzzi , American-college-of-cardiology-annual-scientific-session , Harvard-medical-school , Drug-administration , Baim-institute-for-clinical-research , Journal-of-the-american-college-cardiology , American-college , Annual-scientific , Hutter-family-professor , Massachusetts-general-hospital

Applied Therapeutics (NASDAQ:APLT) Shares Down 3.7%

Shares of Applied Therapeutics, Inc. (NASDAQ:APLT – Get Free Report) were down 3.7% during mid-day trading on Tuesday . The stock traded as low as $5.45 and last traded at $5.45. Approximately 133,499 shares traded hands during mid-day trading, a decline of 94% from the average daily volume of 2,099,365 shares. The stock had previously […]

Canada , United-states , Riccardo-perfetti , Leerink-partnrs , Leslied-funtleyder , Vontobel-holding-ltd , Goldman-sachs-group-inc , Therapeutics-inc , Therapeutics-company-profile , Commonwealth-equity-services , Nasdaq , Royal-bank

Applied Therapeutics (NASDAQ:APLT) Shares Down 3.7%

Applied Therapeutics, Inc. (NASDAQ:APLT – Get Free Report)’s share price was down 3.7% during mid-day trading on Tuesday . The company traded as low as $5.45 and last traded at $5.45. Approximately 133,499 shares traded hands during trading, a decline of 94% from the average daily volume of 2,099,365 shares. The stock had previously closed […]

Canada , United-states , Leerink-partnrs , Leslied-funtleyder , Riccardo-perfetti , Royal-bank , Nasdaq , Citigroup , Capital-management , Armistice-capital , Securities-exchange-commission , Worth-venture-partners

Applied Therapeutics (APLT) to Present Results from Phase 3 ARISE-HF Study in Diabetic Cardiomyopathy at ACC 2024

Applied Therapeutics (APLT) to Present Results from Phase 3 ARISE-HF Study in Diabetic Cardiomyopathy at ACC 2024
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Atlanta , Georgia , United-states , Javed-butler , Gregoryd-lewis , Riccardo-perfetti , Faiez-zannad , Thomash-marwick , Julio-rosenstock , Nasriene-ibrahim , Justina-ezekowitz , Wh-wilson-tang

Short Interest in Applied Therapeutics, Inc. (NASDAQ:APLT) Decreases By 12.5%

Applied Therapeutics, Inc. (NASDAQ:APLT – Get Free Report) saw a large decline in short interest during the month of March. As of March 15th, there was short interest totalling 3,790,000 shares, a decline of 12.5% from the February 29th total of 4,330,000 shares. Based on an average daily volume of 2,120,000 shares, the short-interest ratio […]

United-states , Blackrock , Nova-scotia , Canada , Leerink-partnrs , Riccardo-perfetti , Leslied-funtleyder , Nasdaq , Securities-exchange-commission , Renaissance-technologies , Citigroup , Blackrock-inc

Applied Therapeutics Stock (NASDAQ:APLT), Quotes and News Summary

Applied Therapeutics Stock (NASDAQ: APLT) stock price, news, charts, stock research, profile.

Applied-therapeutics ,

Applied Therapeutics (NASDAQ:APLT) Shares Gap Down to $6.80

Applied Therapeutics, Inc. (NASDAQ:APLT – Get Free Report)’s stock price gapped down before the market opened on Monday . The stock had previously closed at $6.80, but opened at $6.00. Applied Therapeutics shares last traded at $6.31, with a volume of 687,581 shares trading hands. Analyst Ratings Changes Several equities research analysts recently commented on […]

Canada , United-states , Leerink-partnrs , Leslied-funtleyder , Riccardo-perfetti , Royal-bank , Northern-trust-corp , Nasdaq , Therapeutics-inc , Commonwealth-equity-services , Securities-exchange-commission , Citigroup

FDA Presses Delay Button For Applied Therapeutics' First Potential Marketed Drug For Rare Disease - Applied Therapeutics (NASDAQ:APLT)

FDA extends the review period for Applied Therapeutics' NDA for govorestat, targeting Classic Galactosemia treatment. The new action date is set for November 28, 2024. Applied Therapeutics anticipates a decision from EMA in Q4 2024.

Committee-for-medicinal-products-human-use , Therapeutics-inc , Applied-therapeutics-inc , Drug-application , Classic-galactosemia , Prescription-drug-user-fee-act , Applied-therapeutics , Major-amendment , Priority-review , Pediatric-rare-disease , Priority-review-voucher